France begins trials of new COVID vaccine
Other countries
- 25 February, 2021
- 06:11
Add Report.az to preferred Google sources
Stay up to date with the top news!
French biotechnology company Xenothera has begun clinical trials of its coronavirus vaccine, Report informs with reference to TASS.
The vaccine is named Xav-19.
The vaccine testing program follows Polycor standards, one of 15 types of clinical trials of drugs approved by the French medical authorities. The trial will be carried out in 40 hospitals in the country, coordinated by the University Hospital of Nantes.
The drug will be tested on 400 volunteer patients. Currently, 67 patients from 21 hospitals are participating in the trial.
The tests are supposed to determine the level of vaccine effectiveness with great accuracy.
Latest News
00:28
Ali Asadov sends congratulations to Morocco's first female head of government
Foreign policy
00:22
Azerbaijani wrestlers win two gold medals at Vladikavkaz tournament
Individual sports
23:35
Video
President Ilham Aliyev's social media accounts shared video on Cambodian Prime Minister's visit to Azerbaijan
Foreign policy
23:17
Parviz Shahbazov: Oil market stability also depends on safe energy deliveries
Energy
23:11
Georgia seeks role in China-Kyrgyzstan-Uzbekistan transport route
Region
22:34
Education authorities inspect dress-code compliance in Baku schools
Education and science
22:15
Photo
Azerbaijani photo club continues 'landmine-free world' campaign in Sarajevo
Foreign policy
21:59
Shaffer: Military outcome paved way for Armenia-Azerbaijan peace
Foreign policy
21:31
29 foreign ministers accuse Iran of hostile hybrid activities
Other countries